JusGlobal has introduced multi-industry transformational innovations with industry-specific support offering guidance, delivering strategy, monitoring compliance and the regulatory landscape, while also providing legal insight, culminating in the acceleration of multiple advantage points in an unprecedented manner. JusGlobal platforms provide not one, but several added layers of security to business processes that might otherwise be vulnerable to substantial human error, poor record-keeping, faulty data, inefficient document control, insecure networks and potentially crippling litigations.
Meet the Team
From the High Courts of England and Australia to top Wall Street firms, Founder, Chairman, and CEO Beatrice O’Brien brings more than 25 years of legal industry experience to the table. Mrs. O’Brien understands the complex nexus of global business and law that only an international lens can provide. Mrs. O’Brien was the first Fiji Indian attorney working at Wall Street law firm Cadwalader Wickersham & Taft.
Born in Suva in the Fiji Islands, Mrs. O’Brien was educated in Australia and became an (attorney) solicitor and barrister in the New South Wales Supreme Court. A facile legal mind has allowed her to develop a diverse depth of practice in litigation, corporate real estate, banking and tax law having worked in the UK and the US on some of the largest reorganization and restructuring cases in corporate history.
Ever the innovator, Mrs. O’Brien founded and leads Attorney Placements International (API), a global legal search, recruitment and consulting firm that facilitates law firm mergers and acquisitions moving entire legal practice groups to new firms and placing partners and associates with high-profile international clients. As an ardent educator, she has created revolutionary programs such as the New York Bar Review Quality Program which assists international attorneys in qualifying their unique skills and experience to practice in the US market.
Now, Beatrice O’Brien, in founding and leading JusGlobal, is introducing technology innovations backed by an assembly of diverse professionals with the highest credentialing to offer unprecedented insight, guidance and security across the legal, pharmaceutical, health care and military clinical trials space. Ms. O’Brien speaks fluent Hindi.
Duane Lakings delivers a broad array of expertise in various primary areas of drug discovery and development to the JusGlobal enterprise. He is experienced across nonclinical pharmacology, pharmacokinetics and toxicology as well as clinical safety, efficacy, chemistry, manufacturing and control of drug substances and proposed drug products and regulatory affairs. He is the principal and president of Texas-based Drug Safety Evaluation, in which he assists pharmaceutical and biotechnology companies in evaluating results from their drug discovery and development programs, including document preparation, protocol design and implementation across multiple disciplines, as well as further evaluation of drug candidates to support regulatory submission.
Dr. Lakings has served as director of drug safety evaluations at Regeneron Pharmaceuticals in Tarrytown, New York and a senior research investigator II at BMS-PRI (Princeton, NJ). He has been a research scientist at The Upjohn Company in Michigan and he has conducted research for the National Cancer Institute and the University of Missouri-Columbia.
Dr. Lakings has extensive publishing credits. He has authored or co-authored 44 refereed papers and 150 company-specific papers, nine book chapters on drug development, 26 abstracts for oral/poster presentation, eight commissioned drug candidate evaluation reviews and a 300-page report on biological contract research organizations (CROs).
Dr. Lakings holds a PhD, MS and BS from the University of Missouri-Columbia.
Dr. Eyal S. Ron adds value for JusGlobal Pharma clients in the pharmaceutical, biotechnology and medical device space by accelerating the timeline toward the value inflection point. Dr. Ron delivers an entrepreneurial thought process coupled with science-based evaluation to enhance the overarching enterprise value regarding product candidates, without creating a need for costly infrastructure to foster growth.
With three decades of experience in the development of drugs, biomaterials, devices and drug delivery systems, Dr. Ron has become known for combining science with sound business strategy, making him an ideally qualified expert on the JusGlobal team. He developed and implemented the scientific, regulatory and clinical strategy for several companies. Dr. Ron offers extensive depth in the total therapeutic development process including project management, clinical trials, regulatory compliance and approval, drug delivery systems, quality control and scale-up. Dr. Ron has authored more than 100 papers, book chapters and abstracts. He is also the inventor of 50 patents, principally in drug formulations, drug delivery, tissue engineering and biomaterials.
He has been a founder or principal formulator of biotech companies, bringing seven new medications to market. He has held the position of COO, CTO and CSO, director of pharmaceutical development and principal investigator at several pharmaceutical and biotech firms.
Dr. Ron received a PhD from Brandeis University and has completed post graduate study at Massachusetts Institute of Technology. He earned a BS at Tel Aviv University.
Patricia A. Blaine is a registered respiratory therapist, university instructor and accomplished medical writer. She has served as a consultant in clinical trial protocols for leading pharmaceutical companies such as Eisai, Daiichi Sankyo, Forest Laboratories and Schering-Plough.
Ms. Blaine has been a senior director of medical writing and a staff medical writer for Oxford Research, Corning-Besselaar and Schering-Plough. She has been director of clinical education at the University of Medicine and Dentistry of New Jersey (UMDNJ). Ms. Blaine provided medical writing for a poster presented at a psychiatric conference focusing on a Phase IV multi-site investigatory study on carmbamazepine.
Patricia Blaine earned a Master’s degree in Education with a concentration in Allied Health Education from Rutgers University and a Bachelor of Arts in Psychology and English from Seton Hill University (Pennsylvania).